Actively Recruiting
In-hospital and 30-day Prognostication of Acute Heart Failure Patients by Comparing Four Validated Scores in Emergency Department Patients at a Cardiac Hospital
Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2024-05-16
1000
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to determine the prognosis of acute heart failure in patients by comparing four validated risk scores to see which provides better prediction accuracy. It focuses on patients presenting with acute heart failure at a cardiac emergency department and evaluates these scoring systems to improve understanding of patient outcomes over time. Patients who meet eligibility will provide informed consent to use their anonymized data. They will undergo detailed interviews covering demographics and risk factors, and complete validated questionnaires including ADHERE, GWTG-HF Risk Score, OHFRS, and EHMRG30-ST. Participants will be followed for 30 days after hospital admission to record survival status. A sample size of 939 patients has been planned for robust analysis. During the study, data will be verified by cross-checking 10% of records with patient files. Researchers will monitor in-hospital prognosis from admission until discharge or death, and 30-day prognosis from admission up to 30 days. The study involves thorough data collection and follow-up to assess and compare the predictive power of the heart failure risk scores over these periods.
CONDITIONS
Brief Title
Prognostic Model Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Any gender
- Patients who visited the emergency department at NICVD, Karachi
- Newly or previously diagnosed with heart failure
- Able to provide informed consent
- Able to be followed up for 30 days via telephone or outpatient clinic
You will not qualify if you...
- Patients younger than 18 years
- Patients who do not give consent
- Patients with mental handicap due to neurological or psychiatric illness (excluding depression or anxiety)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From admission until discharge or death
Participants undergo interviews and complete questionnaires including patient demographics and risk factors to assess heart failure severity using validated scoring systems.
1 in-hospital period of observation
Duration - 30 days from admission
Participants are followed up to assess survival status and prognosis 30 days after hospital admission.
1 follow-up visit or telephone call
Trial Site Locations
Total: 1 location
1
National Institute of Cardiovascular Diseases
Karachi, Sindh, Pakistan, 75510
Actively Recruiting
Research Team
M
Madiha Fatima, MBBS, FCPS
R
Rajesh Kumar, MBBS, FCPS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here